SCHEMBL23590052

SCHEMBL23590052

CCCCCCCCCOc1ccc(-c2ccc(-c3cc(C(=O)O)c4cc(C(F)(F)F)ccc4n3)nc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 3/20 0.52
▸ PDE10A Q9Y233 1/20 0.49
▸ PLA2G2A P14555 3/20 0.48
▸ EIF4A1 P60842 4/20 0.47
▸ RARB P10826 3/20 0.45
▸ KDM4E B2RXH2 3/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ PTPN11 Q06124 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ PPARD Q03181 1/20 0.43
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23590059 1.00 DHODH (0.52) DHODHPDE10APLA2G2AEIF4A1RARB
SCHEMBL23590062 1.00 DHODH (0.52) DHODHPDE10APLA2G2AEIF4A1RARB
SCHEMBL23590060 1.00 DHODH (0.52) DHODHPDE10APLA2G2AEIF4A1RARB
SCHEMBL23590054 0.99 DHODH (0.52) DHODHPDE10APLA2G2AEIF4A1RARB
SCHEMBL23590051 0.97 DHODH (0.54) DHODHPDE10APLA2G2AEIF4A1RARB
SCHEMBL23590061 0.94 DHODH (0.59) DHODHPDE10APLA2G2AEIF4A1KDM4E
SCHEMBL23594634 0.93 RARB (0.52) DHODHPDE10APLA2G2AEIF4A1RARB
SCHEMBL23590300 0.92 DHODH (0.61) DHODHPDE10APLA2G2AEIF4A1RARB
SCHEMBL23590254 0.92 DHODH (0.61) DHODHPDE10APLA2G2AEIF4A1RARB
SCHEMBL23590297 0.92 DHODH (0.61) DHODHPDE10APLA2G2AEIF4A1RARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed
US-20230109418-A1 COMPOSITIONS FOR USE FOR THE INHIBITION OF DIHYDROOROTATE DEHYDROGENASE OHIO STATE INNOVATION FOUNDATION (US) 2023-04-06 — — US disclosed
WO-2023278778-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD47-SIRPΑ THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-01-05 — — WO disclosed
WO-2021134045-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2021-07-01 — — WO disclosed
WO-2021133831-A1 COMPOSITIONS FOR USE FOR THE INHIBITION OF DIHYDROOROTATE DEHYDROGENASE OHIO STATE INNOVATION FOUNDATION (US) 2021-07-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD DHODH 1/4885PDE10A 3462/4885PLA2G2A 1679/4885
US-20230109418-A1 COMPOSITIONS FOR USE FOR THE INHIBITION OF DIHYDROOROTATE DEHYDROGENASE DHODH, DDO, DLD DHODH 1/4885PDE10A 4280/4885PLA2G2A 3187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback